A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer

Autor: Tolaney, S.M. *, Najita, J., Sperinde, J., Huang, W., Chen, W.Y., Savoie, J., Fornier, M., Winer, E.P., Bunnell, C., Krop, I.E.
Zdroj: In Annals of Oncology July 2013 24(7):1841-1847
Databáze: ScienceDirect